AnalystsSean McCutcheonSean McCutcheon's Stock Forecasts
AnalystsSean McCutcheon
Sectors:
Industries:
Analyst Ranking
Top 34%
#1740 out of 5209 analysts
Average Return
+11.99%
Win Rate
33%4 out of 12
Risk vs Reward
Poor
Good
Sean McCutcheon's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Compass Therapeutics IncCMPX | +120.54% | $2.58 | $5.69 | 2025-06-30 - 2026-03-04 | Buy |
Revolution Medicines IncRVMD | +117.38% | $46.55 | $101.19 | 2025-09-11 - 2026-03-04 | Strong Buy |
Revolution Medicines IncRVMD | +87.04% | $54.10 | $101.19 | 2025-10-16 - 2026-03-04 | Strong Buy |
Vir Biotechnology IncVIR | +69.20% | $5.65 | $9.56 | 2025-07-10 - 2026-03-04 | Buy |
Sean McCutcheon Analyst Color
Get additional color on Sean McCutcheon's coverage of popular stocks
Sean McCutcheon's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bridgebio Oncology Therapeutics IncBBOT | 1 | Buy | $24.00 | +135.99% | Initiates Coverage On | 2 months ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $76.00 | -24.89% | Maintains | 5 months ago |
Vir Biotechnology IncVIR | 1 | Buy | $12.00 | +25.52% | Initiates Coverage On | 8 months ago |
Janux Therapeutics IncJANX | 1 | Buy | $65.00 | +352.96% | Initiates Coverage On | 8 months ago |
Compass Therapeutics IncCMPX | 1 | Buy | $9.00 | +58.17% | Reinstates | 8 months ago |
Black Diamond Therapeutics IncBDTX | 1 | Buy | $11.00 | +347.15% | Reinstates | 8 months ago |
Engene Holdings IncENGN | 1 | Buy | $23.00 | N/A | Initiates Coverage On | a year ago |
Xencor IncXNCR | 1 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Cytokinetics IncCYTK | 2 | Buy | $70.00 | N/A | Maintains | 2 years ago |
Legend Biotech CorpLEGN | 1 | Buy | $86.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.